Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
EuroIntervention. 2021 Oct 20;17(9):765-773. doi: 10.4244/EIJ-D-20-01155.
Delayed diagnosis or misdiagnosis of acute myocardial infarction (AMI) is not unusual in daily practice. Since a 12-lead electrocardiogram (ECG) is crucial for the detection of AMI, a systematic algorithm to strengthen ECG interpretation may have important implications for improving diagnosis.
We aimed to develop a deep learning model (DLM) as a diagnostic support tool based on a 12-lead electrocardiogram.
This retrospective cohort study included 1,051/697 ECGs from 737/287 coronary angiogram (CAG)-validated STEMI/NSTEMI patients and 140,336 ECGs from 76,775 non-AMI patients at the emergency department. The DLM was trained and validated in 80% and 20% of these ECGs. A human-machine competition was conducted. The area under the receiver operating characteristic curve (AUC), sensitivity, and specificity were used to evaluate the performance of the DLM.
The AUC of the DLM for STEMI detection was 0.976 in the human-machine competition, which was significantly better than that of the best physicians. Furthermore, the DLM independently demonstrated sufficient diagnostic capacity for STEMI detection (AUC=0.997; sensitivity, 98.4%; specificity, 96.9%). Regarding NSTEMI detection, the AUC of the combined DLM and conventional cardiac troponin I (cTnI) increased to 0.978, which was better than that of either the DLM (0.877) or cTnI (0.950).
The DLM may serve as a timely, objective and precise diagnostic decision support tool to assist emergency medical system-based networks and frontline physicians in detecting AMI and subsequently initiating reperfusion therapy.
在日常实践中,急性心肌梗死(AMI)的延迟诊断或误诊并不罕见。由于 12 导联心电图(ECG)对于 AMI 的检测至关重要,因此强化 ECG 解读的系统算法可能对改善诊断具有重要意义。
我们旨在开发一种基于 12 导联心电图的深度学习模型(DLM)作为诊断支持工具。
这是一项回顾性队列研究,纳入了来自 737/287 例经冠状动脉造影(CAG)证实的 ST 段抬高型心肌梗死(STEMI)/非 ST 段抬高型心肌梗死(NSTEMI)患者的 1051/697 份 ECG 以及来自急诊科的 76775 例非 AMI 患者的 140336 份 ECG。DLM 在这些 ECG 的 80%和 20%中进行了训练和验证。进行了人机竞争。使用接受者操作特征曲线下的面积(AUC)、敏感性和特异性来评估 DLM 的性能。
在人机竞争中,DLM 检测 STEMI 的 AUC 为 0.976,明显优于最佳医生。此外,DLM 独立显示出足够的 STEMI 检测诊断能力(AUC=0.997;敏感性为 98.4%;特异性为 96.9%)。对于 NSTEMI 检测,联合 DLM 和传统心肌肌钙蛋白 I(cTnI)的 AUC 增加至 0.978,优于 DLM(0.877)或 cTnI(0.950)。
DLM 可作为一种及时、客观、精确的诊断决策支持工具,协助基于急诊医疗系统的网络和一线医生检测 AMI,并随后启动再灌注治疗。